Learn more about MiSight® 1 day from optometrists

MiSight® 1 day

Make MiSight® 1 day your first choice for myopia control

Children lead active, jam-packed lives. But whether they’re playing football, riding bikes with their friends, or learning new things at school, myopia (short-sightedness) can make it harder for them to engage in the activities they love. And as they grow, their prescription may worsen too.

Fortunately, your child may be able to benefit from an innovative technology to help make his or her life easier and help slow down the progression of their myopia.1

MiSight® 1 day is the first and only FDA-approved*† treatment proven to slow the progression of myopia in children aged 8–12 years at the initiation of treatment.1 When wearing MiSight® contact lenses, your child can experience clear vision, freedom from glasses and continue to enjoy the activities they love.1,2,3

The features you'll love

See the Science

  • ActivControl® Technology MiSight® 1 day treatment is dual-purpose: It provides clear vision adn helps control myopia progression.1
  • MiSight® 1 day is the longest soft contact lenses study among children (7 years).1,4,5
  • Cuts myopia progression by approximately 50%.6¶
  • 90% of myopic eyes respond to MiSight® 1 day treatment.4§
  • No need for a stronger prescription at the next annual eye exam in majority of children.1,7||

See the Success

  • 9 out of 10 children prefer MiSight® 1 day contact lenses to spectacles.8
  • Children as young as 8 years old can confidently apply and remove MiSight® 1 day lenses on their own.8
  • 85% of children, with no contact lens-wearing experience, found MiSight® 1 day lenses easy to insert.8

See the Safety

  • 0 serious adverse events related to contact lens wear across a total of 469 patient-wearing years in clinical study.9,10
  • Over 6 years, 99% of all slit lamp observations were ≤grade 1.9#
  • MiSight® 1 day is a single-use lens, with no need for cleaning or storing.
patient information booklet
Patient information booklet
product reminder
Product reminders

Unsure which products are best for you?

Take this four question quiz to discover which of our products may best fit your needs.

Find Your Lens

* Compared to a single vision 1 day lens over a 3-year period.
† As of March 2023. U.S. Indications for Use: MiSight® 1 day (omafilcon A) Soft (Hydrophilic) Contact Lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8–12 years of age and have a refraction of 0.75 to 4.00 dioptres (spherical equivalent) with ≤0.75 dioptres of astigmatism. The lens is to be discarded after each removal.
Using measured and modelled data, pooled across ages (8–17 years), MiSight® 1 day slowed myopia progression by an average of approximately 50%.
§ 90% of myopic eyes respond to MiSight® 1 day treatment; ages 11–15 years at start of wear, n=90.
|| No clinically meaningful change in refractive error (<0.25D from baseline) in years 1–3 of the MiSight® 1 day clinical study.
# Bio-microscopy used 0–4 grading scale

References:
1 Chamberlain P et al. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96(8):556-7.
2 Sulley A, et al. Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. Poster presented at AAO 2019, San Francisco, Calif.
3 Chamberlain P, et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. Presentation at BCLA 2019, Manchester, England.
4 Chamberlain P et al. Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial. Optom Vis Sci. 2022;99(3):204-12.
5 Chamberlain P et al. Myopia progression on cessation of dual-focus contact lens wear: MiSight 1 day 7-year findings. Optom Vis Sci. 2021;98(E-abstract):210049.
6 Arumugam B et al. Modelling age effects of myopia progression for the Misight 1 day clinical trial. Invest Ophthalmol Vis Sci. 2021;62(8):2333.
7 CVI data on file 2021 [MiSight® 1 day data analysis from MIST 401 clinical trial].
8 Sulley A et al. Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children. Optom Vis Sci. 2019;96(E-abstract):195252.
9 Woods J et al. Ocular health of children wearing daily disposable contact lenses over a 6-year period. Cont Lens Anterior Eye. 2021;44(4):101391.
10 CVI data on file, 2022.